CAI FY 2014 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$228M+7.1% YoY

Gross Profit

$150M65.7% margin

Operating Income

$97M42.6% margin

Net Income

$60M26.5% margin

EPS (Diluted)

$2.85

Cash Flow

Operating Cash Flow

$140M

Free Cash Flow

-$168M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.4B

Stockholders' Equity

$442M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$228M	$212M	+7.1%
Gross Profit	$150M	$145M	+3.0%
Operating Income	$97M	$101M	-4.3%
Net Income	$60M	$64M	-5.7%